|
|
PROGRAMFriday, January 9
|
|
|
![]() |
The Hidden Burden: Why cachexia matters |
![]() |
Recognizing and Diagnosing Cancer Cachexia: What every oncologist should know |
![]() |
Current Non Pharmaceutical Therapies for Cancer Cachexia |
![]() |
Pharmacological Management of Cancer Cachexia, Existing and Emerging Therapies |
Explain the biological mechanisms and clinical consequences that contribute to the hidden burden of cancer cachexia and its impact on treatment outcomes.
Apply current diagnostic criteria and assessment tools to accurately recognize and diagnose cancer cachexia in patients with advanced malignancies.
Implement evidence-based non-pharmacologic interventions, including nutritional, metabolic, and exercise-based strategies, to support patients with cancer cachexia.
Evaluate existing and emerging pharmacologic therapies for cancer cachexia and incorporate appropriate treatment options into multidisciplinary care plans.
![]() |
Jose Garcia, MD, PhD – COACH-ED Session Chair President, Cancer Cachexia Society Professor, Department of Medicine |
![]() |
Marcus Goncalves, MD, PhD Clarissa and Edgar Bronfman, Jr. Associate Professor of Endocrinology Director, Holman Division of Endocrinology, Diabetes & Metabolism Director, Systemic Metabolism Research NYU Langone Health |
![]() |
Kathryn Starr, PhD Associate Professor in Medicine |
![]() |
Eric Roeland, MD, FAAHPM, FASCO Associate Professor of Medicine Division of Hematology/Medical Oncology School of Medicine Oregon Health & Science University |